Geode Capital Management
KLRA

Geode Capital Management’s Kailera Therapeutics KLRA Stock Holding History

Geode Capital Management’s Portfolio KLRA Stock Details KLRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25M Buy
+1,133,115
New +$24.9M ﹤0.01% 2020

Other funds holding KLRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Geode Capital Management's KLRA Position: Q2 2026 in Review

Geode Capital Management opened a new position in Kailera Therapeutics (KLRA) in Q2 2026: 1,133,115 shares worth $25M. The stake represents ﹤0.01% of the portfolio and ranks #2020 among its holdings.

30 funds tracked by Wall St. Rank hold KLRA as of Q2 2026.

  • Geode Capital Management held 1,133,115 shares of Kailera Therapeutics worth $25M as of Q2 2026.
  • Kailera Therapeutics was a new Geode Capital Management position in Q2 2026.
  • Kailera Therapeutics made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #2020 holding.
  • 30 funds tracked by Wall St. Rank held Kailera Therapeutics as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.